Suppr超能文献

产后出血的血制品替代治疗。

Blood Product Replacement for Postpartum Hemorrhage.

机构信息

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center.

Division of Critical Care Medicine, Department of Anesthesiology, The Ohio State University, Columbus, Ohio.

出版信息

Clin Obstet Gynecol. 2023 Jun 1;66(2):408-414. doi: 10.1097/GRF.0000000000000766. Epub 2022 Nov 24.

Abstract

Consideration for blood products replacement in postpartum hemorrhage should be given when blood loss exceeds 1.5 L or when an estimated 25% of blood has been lost. In cases of massive hemorrhage, standardized transfusion protocols have been shown to improve maternal morbidity and mortality. Most protocols recommend a balanced transfusion involving a 1:1:1 ratio of packed red blood cells, platelets, and fresh frozen plasma. Alternatives such as cryoprecipitate, fibrinogen concentrate, and prothrombin complex concentrates can be used in select clinical situations. Although transfusion of blood products can be lifesaving, it does have associated risks.

摘要

当出血量超过 1.5L 或估计失血达 25%时,应考虑产后出血时的血液制品替代。在大量出血的情况下,标准化输血方案已被证明可改善产妇的发病率和死亡率。大多数方案建议进行平衡输血,涉及红细胞、血小板和新鲜冷冻血浆的 1:1:1 比例。在某些临床情况下,可以使用冷沉淀、纤维蛋白原浓缩物和凝血酶原复合物浓缩物等替代物。尽管输血可以挽救生命,但确实存在相关风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验